Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.36 |
| ▸ | PPARA | Q07869 | 2/20 | 0.36 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.36 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.36 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.36 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.36 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.36 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.36 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.36 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.36 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.36 |
| ▸ | PTGFR | P43088 | 2/20 | 0.36 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4852949 | 0.91 | PLA2G4B (0.39) | PLA2G4BSLC2A1S1PR1HIF1ATP53 | |
| SCHEMBL63676 | 0.81 | PLA2G4B (0.50) | PLA2G4BS1PR1SMN1; SMN2TBXA2RPTGER1 | |
| SCHEMBL4455826 | 0.81 | PLA2G4B (0.50) | PLA2G4BS1PR1SMN1; SMN2TBXA2RPTGER1 | |
| SCHEMBL183916 | 0.81 | PLA2G4B (0.46) | PLA2G4BS1PR1TP53SMN1; SMN2TBXA2R | |
| SCHEMBL29465911 | 0.79 | PLA2G4B (0.46) | PLA2G4BS1PR1SMN1; SMN2TBXA2RPTGER1 | |
| SCHEMBL29396017 | 0.79 | PLA2G4B (0.46) | PLA2G4BS1PR1SMN1; SMN2TBXA2RPTGER1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1042658 | 0.78 | PLA2G4B (0.44) | PLA2G4BS1PR1SMN1; SMN2PSEN1PSEN2 | |
| SCHEMBL3099626 | 0.78 | PLA2G4B (0.44) | PLA2G4BS1PR1SMN1; SMN2TBXA2RPTGER1 | |
| SCHEMBL28789833 | 0.77 | PLA2G4B (0.43) | PLA2G4BS1PR1TP53SMN1; SMN2PPARG | |
| SCHEMBL21990 | 0.76 | PLA2G4B (0.55) | PLA2G4BS1PR1OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1591097-B1 | Cationically curing two component materials containing a noble metal catalyst | MINNESOTA MINING MFG GMBH (DE) | 2012-06-20 | — | — | EP | disclosed |
| US-7368524-B2 | Cationically curing two component materials containing a noble metal catalyst | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-05-06 | — | — | US | disclosed |
| US-20060116445-A1 | Cationically curing two component materials containing a noble metal catalyst | 3M DEUTSCHLAND GMBH (DE) | 2006-06-01 | — | — | US | disclosed |
| EP-1591097-A1 | Cationically curing two component materials containing a noble metal catalyst | 3M Espe AG (DE) | 2005-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060116445-A1 | Cationically curing two component materials containing a noble metal catalyst | CAD, ELL, MEP1A | PLA2G4B 822/4885SLC2A1 4665/4885S1PR1 4598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.